Visualizaciones | |
---|---|
Loss of expression of muscleblind-like 1 (MBNL1) promotes doxorubicin resistance through BIN1/c-MYC/PARP1 axis regulation in triple negative breast cancer | 149 |
enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | mayo 2024 | junio 2024 | julio 2024 | |
---|---|---|---|---|---|---|---|
Loss of expression of muscleblind-like 1 (MBNL1) promotes doxorubicin resistance through BIN1/c-MYC/PARP1 axis regulation in triple negative breast cancer | 4 | 6 | 0 | 2 | 20 | 10 | 2 |
Visualizaciones | |
---|---|
Aleixos - La perdida de expresion de muscleblind-like 1 MBNL1 promueve la resistencia a doxorrubi....pdf | 2 |
1 |
Visualizaciones | |
---|---|
Estados Unidos | 41 |
China | 32 |
España | 28 |
México | 10 |
Francia | 8 |
Alemania | 4 |
Irlanda | 4 |
Reino Unido | 3 |
Italia | 3 |
Japón | 3 |
Visualizaciones | |
---|---|
Houston | 12 |
Hangzhou | 11 |
Alameda | 6 |
Louisville | 6 |
Grenoble | 5 |
Mountain View | 5 |
Valencia | 5 |
Dublin | 4 |
Zhengzhou | 4 |
Alicante | 3 |